Showing: 1 - 3 of 3 RESULTS

Zoom is releasing a new tool to let paid users charge for admission to online events like conferences or fitness classes



Eric S. Yuan standing in front of a sign: Eric Yuan, CEO of Zoom Video Communications takes part in a bell ringing ceremony at the NASDAQ MarketSite in New York Reuters


© Provided by Business Insider
Eric Yuan, CEO of Zoom Video Communications takes part in a bell ringing ceremony at the NASDAQ MarketSite in New York Reuters

  • Zoom is introducing OnZoom, a new way to host events — free and paid — using the popular videoconferencing tool.
  • Zoom has come to be used to host all kinds of events amid the pandemic, from board meetings and conferences to fitness classes and concerts. The new OnZoom platform includes the ability to charge for tickets, as well as a directory of public event listings.
  • Zoom is also launching a new kind of app integration, called a Zapp, that can bring information from productivity tools like Dropbox, Slack, or Asana directly into a video chat.
  • Facebook launched its own features for paid videoconferencing events over the summer.
  • Visit Business Insider’s homepage for more stories.

As the pandemic drags on, Zoom is releasing a new way to host online events — importantly, now including paid events — as well as new types of apps that integrate outside business and productivity tools like Slack, Dropbox, and Asana directly into Zoom meetings, the company announced Wednesday. 

Loading...

Load Error

Zoom has become a household name amid shelter in place and social distancing mandates, with users turning to the videoconferencing app to host events from board meetings and conferences to yoga classes and concerts. It’s led Zoom’s business to skyrocket, but also forced the company to rethink its ambitions beyond its original enterprise approach. 

The online event platform, called OnZoom, adds features to Zoom that make it easier to host online events — notably, by allowing event organizers to sell tickets for paid events on Zoom, thanks to an integration with PayPal. There will also be an event marketplace, where people can find and sign up for public events, free and paid.

At launch, the events platform is only available to US users, but will be available more globally next year. There’s no additional fee for paid users to try out OnZoom through the end of 2020, but Zoom says that it plans to revisit the possibility of taking a cut of ticket sales next year. 

Notably, Facebook announced something similar earlier this year, allowing businesses, creators, educators and media publishers to host paid events on Facebook Live or its Messenger Rooms app. Facebook has said it won’t collect fees from tickets sales until at least August 2021.

The catch is that you will have to be a paid Zoom user to set up events with OnZoom, with a capacity ranging from 100 attendees, up to 1,000 for enterprise users. For anything larger, users can livestream the event with a Zoom Webinar license. 

OnZoom is actually getting its first public test right out in the open: Zoom is using it to host its annual Zoomtopia user conference this week. The company bills it as being well-suited for other companies to host their own conferences, for fitness instructors to hold paid lessons, for nonprofits to set up fundraising events

Pear Therapeutics to Participate in Upcoming Investor Conferences

Pear Therapeutics, Inc. today announced management’s participation in three virtual investor conferences in October 2020:

  • Cowen 9th Annual MedTools Conference – Answers Unlocked. Corey McCann, M.D., Ph.D., President and CEO, will participate in a panel discussion, Digital Therapeutics, at this virtual conference on Thursday, October 15, 2020 at 8:30 a.m. ET.

  • 7th Solebury Trout Private Company Showcase Co-Hosted by BMO and Davis Polk. Corey McCann will present at this virtual conference on Thursday, October 15, 2020 at 11:40 a.m. ET.

  • HLTH VRTL 2020 Conference – Evercore ISI Panel Series Digging into Digital Therapeutics: A New Dimension in Treatment. Corey McCann will participate in a panel discussion, CEOs on DTx, at this virtual conference on Friday, October 16, 2020 at 11:00 a.m. ET.

Pear Therapeutics is a privately held, prescription digital therapeutics company developing clinically validated, FDA-authorized software applications to treat serious disease.

About Pear Therapeutics
Pear Therapeutics is the leader in prescription digital therapeutics, or PDTs. Pear aims to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has a pipeline of products and product candidates across therapeutic areas, including the first three PDTs with disease treatment claims from FDA. Pear’s lead product, reSET®, for the treatment of substance use disorder, was the first PDT to receive marketing authorization from FDA to treat disease. Pear’s second product, reSET-O®, for the treatment of opioid use disorder, was the first PDT to receive Breakthrough Designation. Pear’s third product, Somryst™, for the treatment of chronic insomnia, was the first PDT submitted through FDA’s traditional 510(k) pathway while simultaneously reviewed through FDA’s Software Precertification Pilot Program. For more information, visit Pear at www.peartherapeutics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201008005153/en/

Contacts

Media and Investors:
Meara Murphy, Director, Corporate Communications
[email protected]

 

Source Article

Abu Dhabi Stem Cells Center and Pluristem Unveil Joint Projects at Malta Conferences Foundation Online Event

 

On Wednesday, September 30, 2020, Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading Israeli regenerative medicine company developing a platform of novel biological products, and the Abu Dhabi Stem Cells Center (ADSCC) unveiled their first joint projects in a presentation at the Malta Conferences Foundation (MCF), a global conference supported by kENUP Foundation, a promoter of research-based innovation with public and societal benefit.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201001005476/en/

Malta Conferences address shared desire to improve quality of life and political stability in Middle East through scientific collaboration (Graphic: Business Wire)

Pluristem and ADSCC presented new projects, part of the recently signed Memorandum of Understanding aimed at harnessing the power of regenerative medicine.

The first joint project brings together the expertise of Pluristem and ADSCC to advance a potential COVID-19 treatment. The project will involve the first-time administration of Pluristem’s PLX cells via a nebulizer, a drug delivery device that helps a patient inhale medication through a mask or mouthpiece, to COVID-19 patients. The collaboration allows ADSCC to expand their stem cell therapy options using Pluristem’s PLX cells, while enabling Pluristem to leverage ADSCC’s nebulizer administration experience to develop a new treatment delivery model for PLX cells. ADSCC has reported effectively using nebulizers to treat COVID-19 patients with stem cells sourced from the patient’s own blood.

Further discussions for additional projects are underway, including for potential collaboration in chronic Graft Versus Host Disease (cGvHD), a life-threatening immune response of the donor’s stem cells against the host (patient).

The parties presented the joint projects to a distinguished audience at the MCF, including Nobel Laureates, scientists, and diplomats. The foundation’s mission is to address the shared desire to improve quality of life and political stability in the Middle East by identifying opportunities for collaboration to meet the scientific and technological challenges of the region.

“I am delighted for the opportunity to convene this important meeting. The Malta Conferences are the only platform in the world where scientists from 15 Middle East countries, Morocco and Pakistan can get together under the same roof with several Nobel Laureates. They develop collaborations and friendship which overcome the chasms of distrust and intolerance.” said Prof. Zafra Lerman, President of Malta Conferences Foundation.

“Embarking on this journey with Pluristem to overcome one of this generation’s most complex medical challenges marks an exciting new chapter full of possibilities when it comes to knowledge sharing and medical innovation. Our partnership speaks volumes about the power of collaboration between partners across previously divided borders. While we simply do not yet know the long-term impact the novel coronavirus will have on recovered patients, by working together we believe we are able to leverage the best medical technologies and minds in the region to develop solutions to prevent and treat the lingering symptoms and long-term complications that are emerging.” said Dr. Yendry Ventura, General Manager of ADSCC.

“We were very honored to unveil our first joint projects with the ADSCC at the MCF. We see our